萬孚生物(300482.SZ):擬向招商銀行廣州分行申請2億元綜合授信額度
格隆匯6月17日丨萬孚生物(300482.SZ)公佈,公司於2021年6月17日召開第四屆董事會第一次會議,審議通過了《關於向相關銀行申請銀行綜合信用授信額度的議案》。
為保證公司經營活動的正常開展,公司擬向招商銀行股份有限公司廣州分行申請2億元人民幣綜合授信額度,以公司信用作為擔保。
公司授權董事長王繼華代表公司與招商銀行股份有限公司廣州分行簽署本次授信有關的法律文件,自董事會審批通過之日起有效期12個月。
此次申請授信額度事項在董事會決策範圍內,無需提交股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.